Merck Executive and Leadership Team

Robert Davis, the Chairman & Chief Executive Officer at Merck, directs the company's overarching strategy and global operations. Davis guides Merck's mission to deliver innovative healthcare solutions, encompassing prescription medicines, biologic therapies, vaccines, and animal health products. This leadership role involves setting the strategic vision for research and development, ensuring robust pipeline progression, and optimizing market access for critical therapies worldwide. By fostering a culture of scientific excellence and ethical conduct, Davis drives the company's commitment to improving patient outcomes and advancing global health. The Chairman & Chief Executive Officer ensures alignment across all business units, from pharmaceuticals to animal health, to achieve sustainable growth and long-term value creation. Davis's strategic oversight extends to capital allocation, investor relations, and corporate governance, solidifying Merck's position as a leader in the healthcare industry. This executive's focus remains on pioneering advancements that address unmet medical needs and enhance the well-being of people and animals globally.

James Hall, the Chief Financial Officer, Ghh Market (US) at Merck, directs the financial strategy and operations for the company's Global Health and Health (GHH) market within the United States. Hall oversees all financial planning, analysis, and reporting activities, ensuring fiscal responsibility and strategic resource allocation to support Merck's healthcare initiatives. This leadership role involves managing budgets, optimizing financial performance, and driving profitability for key product lines, including prescription medicines, vaccines, and animal health products in the US market. The Chief Financial Officer, Ghh Market (US) plays a critical part in evaluating investment opportunities, managing financial risks, and ensuring compliance with financial regulations. Hall's expertise is essential for guiding the financial direction of the GHH market, enabling Merck to achieve its objectives of improving patient outcomes and advancing global health. This executive's financial acumen underpins Merck's ability to innovate and deliver essential healthcare solutions.

Henry Leqi, the Director, Chief of Staff To China President at Merck, provides essential strategic and operational leadership for Merck's operations within the China market. Leqi supports the China President in executing regional business strategies, ensuring seamless coordination across various functions to advance Merck's healthcare solutions. This role involves managing key initiatives, facilitating communication between local teams and global headquarters, and optimizing operational processes to enhance market penetration for prescription medicines, biologic therapies, and vaccines. The Director, Chief of Staff To China President plays a crucial part in navigating the complexities of the Chinese healthcare landscape, driving growth and ensuring compliance with local regulations. Leqi's responsibilities include supporting strategic planning, overseeing project execution, and fostering strong relationships with stakeholders to advance Merck's mission of improving health outcomes in the region. This executive's leadership is instrumental in strengthening Merck's presence and impact in China.

Elena Kostyukova, the Chief of Staff at Merck, provides critical strategic support and operational coordination for executive leadership. Kostyukova facilitates the execution of key initiatives, ensuring seamless communication and alignment across diverse departments. This role involves managing complex projects, streamlining internal processes, and enhancing organizational efficiency to support Merck's global healthcare mission. By acting as a central point of contact for strategic priorities, Kostyukova enables the executive team to focus on innovation in prescription medicines, biologic therapies, vaccines, and animal health products. The Chief of Staff drives cross-functional collaboration, ensuring that strategic objectives are translated into actionable plans and that progress is effectively monitored. Kostyukova's responsibilities include preparing executive briefings, coordinating board-level communications, and optimizing resource allocation to support Merck's commitment to scientific advancement and patient well-being. This executive's efforts are vital for maintaining operational agility and driving forward the company's ambitious goals in the pharmaceutical and animal health sectors.

Kimberley Brokaw, the Merck Research Laboratories IT & Investment Lead Chief of Staff at Merck, spearheads strategic initiatives within the critical research and development arm of the company. Brokaw directs IT investments and operational strategies, ensuring that Merck's research laboratories are equipped with cutting-edge technology and resources to drive innovation in drug discovery and development. This leadership position involves aligning IT infrastructure and investment priorities with the scientific objectives of Merck Research Laboratories, supporting the creation of novel prescription medicines and biologic therapies. The Merck Research Laboratories IT & Investment Lead Chief of Staff oversees the efficient allocation of capital for technology upgrades, data management systems, and computational resources essential for advancing vaccine development and animal health solutions. Brokaw's role is pivotal in optimizing the operational effectiveness of the research division, enabling scientists to accelerate the pace of innovation and bring life-changing treatments to market. This executive ensures that technological advancements directly support Merck's mission to improve global health outcomes through scientific breakthroughs.

Nikhil Meledath, the Senior Product Analyst & Associate Product Manager & Chief Technology Officer, Mrl-Information Technology Ctm- Product Management at Merck, drives technological innovation and product management within the research and development division. Meledath oversees the strategic direction of IT solutions and product development, ensuring alignment with Merck's mission to deliver groundbreaking healthcare products. This multifaceted role involves analyzing market needs, managing product lifecycles, and implementing advanced technology strategies to support the creation of novel prescription medicines, biologic therapies, and vaccines. The Senior Product Analyst & Associate Product Manager & Chief Technology Officer, Mrl-Information Technology Ctm- Product Management ensures that IT infrastructure and product roadmaps effectively support scientific discovery and operational efficiency across Merck Research Laboratories. Meledath's expertise bridges technology and product strategy, facilitating the translation of scientific insights into tangible healthcare solutions that address unmet medical needs. This executive's focus is on leveraging technology to accelerate innovation and enhance the impact of Merck's pharmaceutical and vaccine portfolios.

Neda Kazeruni, the Strategic Chief of Staff at Merck, drives critical strategic planning and execution across key business units. Kazeruni collaborates closely with executive leadership to translate high-level objectives into actionable plans, ensuring alignment with Merck's mission to deliver innovative healthcare solutions. This role involves managing cross-functional projects, identifying strategic opportunities, and optimizing operational frameworks to support the development and delivery of prescription medicines, biologic therapies, vaccines, and animal health products. The Strategic Chief of Staff enhances organizational effectiveness by streamlining communication channels, facilitating decision-making processes, and ensuring that strategic priorities are effectively implemented. Kazeruni's focus is on driving efficiency and impact, enabling Merck to accelerate scientific discovery and bring life-changing treatments to patients and animals worldwide. This executive's contributions are vital for maintaining strategic momentum and achieving Merck's ambitious goals in global health.

James Young, the Regional Chief of Staff, Business Practices, Early Assets, Comm For Latin America Operations Lead at Merck, directs operational strategy and business practices across Latin America. Young oversees the coordination of early-stage asset development and communication strategies, ensuring alignment with Merck's global mission to advance healthcare solutions. This leadership position involves managing regional operations, implementing best practices, and fostering collaboration to support the delivery of prescription medicines, biologic therapies, and vaccines throughout Latin America. The Regional Chief of Staff, Business Practices, Early Assets, Comm For Latin America Operations Lead plays a key role in optimizing the commercialization and distribution of Merck's innovative products within the region. Young's responsibilities include driving operational efficiency, ensuring regulatory compliance, and supporting the strategic growth of Merck's business in Latin America. This executive's leadership is essential for expanding access to critical healthcare interventions and enhancing patient well-being across the continent.

Francis Geatens, the Chief Technology Officer & Senior VP at Merck, architects the company's global technology strategy and infrastructure. Geatens leads the integration of advanced technologies to support Merck's mission of delivering innovative healthcare solutions, including prescription medicines, biologic therapies, vaccines, and animal health products. This executive role involves overseeing all aspects of information technology, cybersecurity, and digital transformation initiatives, ensuring robust and secure systems that empower scientific research and operational excellence. The Chief Technology Officer & Senior VP drives the adoption of cutting-edge digital tools and platforms, enhancing data analytics capabilities and accelerating drug discovery and development processes. Geatens's strategic vision ensures that Merck's technological capabilities remain at the forefront of the industry, enabling the company to address complex global health challenges effectively. This leadership ensures that technology serves as a critical enabler for Merck's commitment to improving lives worldwide.

Rashid Beyah, the Global Supply Chain Management Chief of Staff at Merck, optimizes the efficiency and resilience of Merck's worldwide supply chain operations. Beyah supports the strategic direction of supply chain management, ensuring the timely and secure delivery of critical healthcare products, including prescription medicines, biologic therapies, and vaccines. This role involves coordinating logistics, managing inventory, and implementing advanced supply chain technologies to enhance operational performance and mitigate risks across global markets. The Global Supply Chain Management Chief of Staff plays a vital part in ensuring that Merck's products reach patients and healthcare providers reliably, supporting the company's commitment to global health. Beyah's focus is on driving continuous improvement, fostering collaboration with supply chain partners, and ensuring that the supply chain effectively supports Merck's mission to save and improve lives. This executive's leadership is crucial for maintaining the integrity and responsiveness of Merck's global distribution network.